Insights
Why We Invested in Headlands Research: Advancing the Future of Clinical Trials
Key Takeaways: In August 2025, THL announced a majority investment in Headlands Research, a leading North American network of clinical trial sites that partners directly with pharmaceutical sponsors and CROs to advance medical research and help bring new therapies to market. As therapies grow more complex and trials demand greater inclusivity, execution has become one of the
Healthcare (HC)